Concepedia

Wendy Ankrom

WA

Statistics

Publications

8

Citations

195

H-Index

8

Active since

2016

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Celerion (United States)

Thomas Jefferson University

Allergan (United States)

Wendy Ankrom is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, pharmacokinetics, and clinical pharmacology.

ORCID

Publications per year

2016–2024

8

Publications

8

Safety, tolerability, and pharmacokinetics of single‐ and multiple‐dose administration of islatravir (MK‐8591) in adults without HIV

Randolph P. Matthews, Wendy Ankrom, Evan Friedman et al. · Clinical and Translational Science · 2021 · 46 citations · Full text

, , +16

Atogepant Has No Clinically Relevant Effects on the Pharmacokinetics of an Ethinyl Estradiol/Levonorgestrel Oral Contraceptive in Healthy Female Participants

Wendy Ankrom, Jialin Xu, Marie‐Helene Vallee et al. · The Journal of Clinical Pharmacology · 2020 · 44 citations · Full text

, , +17

Severe Renal Impairment Has Minimal Impact on Doravirine Pharmacokinetics

Wendy Ankrom, Ka Lai Yee, Rosa I. Sánchez et al. · Antimicrobial Agents and Chemotherapy · 2018 · 24 citations · Full text

, , +16

Ubrogepant Is Not Associated With Clinically Meaningful Elevations of Alanine Aminotransferase in Healthy Adult Males

Wendy Ankrom, Phung Bondiskey, Chi‐Chung Li et al. · Clinical and Translational Science · 2020 · 24 citations · Full text

, , +15

Preclinical and translational evaluation of coagulation factor IXa as a novel therapeutic target

Wendy Ankrom, Harold B. Wood, Jiayi Xu et al. · Pharmacology Research & Perspectives · 2016 · 18 citations · Full text

, , +17

1–5 of 8